Trial Profile
IC 41 and nitazoxanide in patients with hepatitis C
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2011
Price :
$35
*
At a glance
- Drugs IC 41 (Primary) ; Nitazoxanide (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 09 Nov 2010 The trial is expected to be initiated in the first half of 2011, according to an Intercell media release.
- 22 Oct 2010 New trial record